Episode
Portugal, Spain and the new biotech frontier
- Podcast
- BioSpace
- Published
- Jun 10, 2026
- Duration seconds
- 1233
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/portugal-spain-and-the-new-biotech-frontier/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/biospace-6696251/portugal-spain-and-the-new-biotech-frontier.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you'll hear from Hannah Franklin, associate at Biovance Capital and Pablo Gabriel Cironi Lopez, director of life science investment at Caixa Capital Risc. We examine the rise of Southern Europe’s biotech ecosystem—from Portugal’s efforts to turn strong science into startups to Spain’s growing depth of capital and talent—and what it will take for the region to compete globally. Host Jennifer C. Smith-Parker , Director of Insights, BioSpace Guests Hannah Franklin , Associate, Biovance Capital Pablo Gabriel Cironi Lopez , Director, Life Science Investment, Caixa Capital Risc Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.